designer491/iStock via Getty Images
Valneva (NASDAQ:VALN) ADRs fell on Wednesday after the French biotech said that the EU drug regulator, the European Medicines Agency (EMA), has suspended the use of its chikungunya vaccine, Ixchiq, in older adults following safety concerns.
The decision follows 17